CURX
Curanex Pharmaceuticals Inc Common Stock
NASDAQ: CURX · HEALTHCARE · BIOTECHNOLOGY
$0.42
+0.72% today
Updated 2026-04-30
Market cap
$12.38M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.02
Dividend yield
—
52W range
$0 – $9
Volume
5.3M
Curanex Pharmaceuticals Inc Common Stock (CURX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $3336.00 | $-120.00 | $-555575.00 | $-10.48M |
| Capital expenditures | $0.00 | $0.00 | $5.00 | $0.00 |
| Depreciation | — | — | — | — |
| Stock-based comp | — | — | — | — |
| Free cash flow | $3336.00 | $-120.00 | $-555580.00 | $-10.48M |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |